AMRN Quote, Trading Chart, Amarin Corporation plc
home / stock / amrn / amrn quote
$4.93 Last:
0.82% Change Percent:
$4.89 Open:
$4.93 Previous Close:
$4.98 High:
$4.83 Low:
2,421,790 Volume:
06/17/2021 04:42:30 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
AMRN Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-17 | 4.89 | 4.93 | 4.98 | 4.83 | 2,421,790 |
| 2021-06-16 | 4.88 | 4.89 | 4.955 | 4.795 | 1,820,416 |
| 2021-06-15 | 4.9917 | 4.92 | 5 | 4.8 | 2,733,803 |
| 2021-06-14 | 4.94 | 5 | 5.06 | 4.91 | 2,384,078 |
| 2021-06-11 | 4.93 | 4.95 | 4.965 | 4.845 | 1,852,395 |
| 2021-06-10 | 4.84 | 4.88 | 4.92 | 4.82 | 2,144,400 |
| 2021-06-09 | 4.92 | 4.88 | 5.02 | 4.85 | 2,702,161 |
| 2021-06-08 | 4.85 | 4.89 | 4.96 | 4.77 | 3,824,066 |
| 2021-06-07 | 4.45 | 4.76 | 4.78 | 4.42 | 3,913,492 |
| 2021-06-04 | 4.58 | 4.45 | 4.59 | 4.435 | 3,167,730 |
| 2021-06-03 | 4.55 | 4.59 | 4.7 | 4.54 | 2,261,548 |
| 2021-06-02 | 4.58 | 4.59 | 4.6459 | 4.52 | 2,330,076 |
| 2021-06-01 | 4.55 | 4.6 | 4.615 | 4.47 | 2,475,246 |
| 2021-05-31 | 4.57 | 4.54 | 4.72 | 4.53 | 1,749,362 |
| 2021-05-28 | 4.57 | 4.54 | 4.72 | 4.53 | 1,740,762 |
| 2021-05-27 | 4.6 | 4.62 | 4.68 | 4.54 | 1,798,856 |
| 2021-05-26 | 4.35 | 4.59 | 4.605 | 4.33 | 3,189,383 |
| 2021-05-25 | 4.42 | 4.35 | 4.5 | 4.32 | 2,453,174 |
| 2021-05-24 | 4.57 | 4.41 | 4.59 | 4.4001 | 1,738,336 |
| 2021-05-21 | 4.6 | 4.56 | 4.63 | 4.53 | 1,854,046 |
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
DUBLIN, Ireland and BRIDGEWATER, N.J., June 02, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the presentation of further insights into various potential mechanisms of action of icosapent ethyl and differences in biological actions of the unique form of eicos...
-
Amarin (NASDAQ: AMRN) rose to end Tuesday nearly 5.1% higher after the company provided details from clinical studies of the components of its one commercialized drug. In a presentation at the American College of Cardiology's Annual Scientific Session, Amarin presented findings ...
-
DUBLIN, Ireland and BRIDGEWATER, N.J., May 18, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that John F. Thero, Amarin's president and chief executive officer, and Karim Mikhail, Amarin’s senior vice president and head of commercial for Europe and fut...